SDI (SDI) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
27 Nov, 2025Opening remarks and agenda
Meeting opened virtually with procedural and technical instructions for online participation and voting.
Shareholders guided on how to vote and submit questions during the meeting.
Introduction of board members, executive team, and auditor; speeches released to the market.
Financial performance review
FY 2025 normalized after-tax profit was AUD 10.5 million, up 0.1% from last year.
Sales reached AUD 110.4 million, down 0.7% on FY 2024, with growth in aesthetic and whitening products.
Gross profit margin increased by 80 basis points to 62.9% due to product mix and efficiencies.
EBITDA fell 2.7% to AUD 21.6 million; operating expenses were well managed.
Regional performance was mixed: Europe and Brazil saw growth, while Australia and North America declined.
Board and executive committee updates
Directors and executive team introduced, with emphasis on their ongoing contributions.
Board renewal and succession discussed, with no immediate plans for changes.
Directors up for re-election received unanimous board support.
Latest events from SDI
- Shareholders voted on a recommended acquisition Scheme, with results to be released to the ASX.SDI
Scheme meeting 202622 Jun 2026 - Gross margin rose to 62.9% as automation and new products offset flat sales and falling amalgam.SDI
H2 202512 Jun 2026 - Record profit and margin growth led by Aesthetics, with automation and site expansion fueling outlook.SDI
H2 202412 Jun 2026 - Net profit up 3.5% to AUD 3.8m as margin gains and Aesthetics growth offset regional declines.SDI
H1 202512 Jun 2026 - Revenue up 2.7%, NPAT down 15.2%, with strong Aesthetics growth and acquisition talks ongoing.SDI
H1 20268 Mar 2026 - Record profit, strong product launches, and major manufacturing upgrades drive future growth.SDI
AGM 202412 Jan 2026